T. BARLAS Et Al. , "Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushings syndrome and the vanishing effect of octreotide therapy," The Endocrine Society , vol.2, 2024
BARLAS, T. Et Al. 2024. Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushings syndrome and the vanishing effect of octreotide therapy. The Endocrine Society , vol.2 .
BARLAS, T., KAYHAN, G., YALÇIN, M. M., CERİT, E. T., AKTÜRK, M. Y., TÖRÜNER, F. S., ... SÖZEN, T. S.(2024). Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushings syndrome and the vanishing effect of octreotide therapy. The Endocrine Society , vol.2.
BARLAS, TUĞBA Et Al. "Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushings syndrome and the vanishing effect of octreotide therapy," The Endocrine Society , vol.2, 2024
BARLAS, TUĞBA Et Al. "Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushings syndrome and the vanishing effect of octreotide therapy." The Endocrine Society , vol.2, 2024
BARLAS, T. Et Al. (2024) . "Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushings syndrome and the vanishing effect of octreotide therapy." The Endocrine Society , vol.2.
@article{article, author={TUĞBA BARLAS Et Al. }, title={Inactivation of KDM1A with the concurrent presence of MGUS in a patient with GIP-dependent Cushings syndrome and the vanishing effect of octreotide therapy}, journal={The Endocrine Society}, year=2024}